These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3480222)

  • 21. Lack of effect of aciclovir on metabolism of theophylline and expression of hepatic cytochrome P450 1A2 in rats.
    Nadai M; Kato M; Yasui K; Kimura M; Zhao YL; Ueyama J; Tsunekawa Y; Yoshizumi H; Hasegawa T
    Biol Pharm Bull; 2007 Mar; 30(3):562-8. PubMed ID: 17329857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of 2 quinolone antibacterials, temafloxacin and enoxacin, on theophylline pharmacokinetics.
    Sörgel F; Mahr G; Granneman GR; Stephan U; Nickel P; Muth P
    Clin Pharmacokinet; 1992; 22 Suppl 1():65-74. PubMed ID: 1319873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation between plasma and saliva concentrations of enoxacin, ciprofloxacin, and theophylline.
    Zhai S; Wei X; Parker BM; Kunze KL; Vestal RE
    Ther Drug Monit; 1996 Dec; 18(6):666-71. PubMed ID: 8946663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of enoxacin, ofloxacin and norfloxacin on theophylline disposition in humans.
    Sano M; Kawakatsu K; Ohkita C; Yamamoto I; Takeyama M; Yamashina H; Goto M
    Eur J Clin Pharmacol; 1988; 35(2):161-5. PubMed ID: 3191935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2.
    Kinzig-Schippers M; Fuhr U; Zaigler M; Dammeyer J; Rüsing G; Labedzki A; Bulitta J; Sörgel F
    Clin Pharmacol Ther; 1999 Mar; 65(3):262-74. PubMed ID: 10096258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of drug metabolism by quinolone antibiotics.
    Edwards DJ; Bowles SK; Svensson CK; Rybak MJ
    Clin Pharmacokinet; 1988 Sep; 15(3):194-204. PubMed ID: 3052987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Theophylline dosage adjustment during enoxacin coadministration.
    Koup JR; Toothaker RD; Posvar E; Sedman AJ; Colburn WA
    Antimicrob Agents Chemother; 1990 May; 34(5):803-7. PubMed ID: 2360819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of quinolones on xanthine pharmacokinetics.
    Robson RA
    Am J Med; 1992 Apr; 92(4A):22S-25S. PubMed ID: 1580270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of multiple-dose oral lomefloxacin on theophylline metabolism in man.
    Wijnands GJ; Cornel JH; Martea M; Vree TB
    Chest; 1990 Dec; 98(6):1440-4. PubMed ID: 2245687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of enoxacin with theophylline in rats.
    Mizuki Y; Kamaura M; Yamaguchi T; Sekine Y; Hashimoto M
    Arzneimittelforschung; 1989 May; 39(5):593-7. PubMed ID: 2757677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of interaction between theophylline and mexiletine.
    Ueno K; Miyai K; Kato M; Kawaguchi Y; Suzuki T
    DICP; 1991; 25(7-8):727-30. PubMed ID: 1949927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential theophylline toxicity with enoxacin.
    Wijnands GJ; Vree TB; van Herwaarden CL
    Drug Intell Clin Pharm; 1987 Apr; 21(4):383. PubMed ID: 3471434
    [No Abstract]   [Full Text] [Related]  

  • 33. Lack of clinically important interaction between erythromycin and theophylline.
    Hildebrandt R; Gundert-Remy U; Möller H; Weber E
    Eur J Clin Pharmacol; 1984; 26(4):485-9. PubMed ID: 6734707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of theophylline by cDNA-expressed human cytochromes P-450.
    Ha HR; Chen J; Freiburghaus AU; Follath F
    Br J Clin Pharmacol; 1995 Mar; 39(3):321-6. PubMed ID: 7619675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary metabolism of theophylline biotransformation products in man--route of formation of 1-methyluric acid.
    Birkett DJ; Miners JO; Attwood J
    Br J Clin Pharmacol; 1983 Jan; 15(1):117-9. PubMed ID: 6849735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Theophylline metabolism by human, rabbit and rat liver microsomes and by purified forms of cytochrome P450.
    McManus ME; Miners JO; Gregor D; Stupans I; Birkett DJ
    J Pharm Pharmacol; 1988 Jun; 40(6):388-91. PubMed ID: 2901468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Enoxacin and theophylline].
    Infection; 1986; 14 Suppl 3():S220. PubMed ID: 3463547
    [No Abstract]   [Full Text] [Related]  

  • 38. Enoxacin distribution in human tissues after multiple oral administration.
    Malmborg AS; Rannikko S
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():57-60. PubMed ID: 3162902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.
    Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
    Drugs; 1987; 34 Suppl 1():159-69. PubMed ID: 3481317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of increased caffeine intake on the metabolism and pharmacokinetics of theophylline in man.
    Monks TJ; Lawrie CA; Caldwell J
    Biopharm Drug Dispos; 1981; 2(1):31-7. PubMed ID: 7236869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.